Takeda Pharmaceutical Co. Ltd.

2016 Revenue (US$ Millions)$14,809
Revenue Growth (%)-4.17%
Net Income (US$ Millions)$983
Earnings Per Share (US$)$1.25
EPS Growth Rate (%)43.80%
Profit Margin6.64%
Total Equity (US$ Millions)$16,196
Return on Equity (%)5.90%
Long Term Debt (US$ Millions)$5,129
Debt To Equity Ratio (%)0.32%
Total Assets (US$ Millions)$37,242
Current Assets (US$ Millions)$10,779
Current Liabilities (US$ Millions)$11,680
Cost of Goods Sold (US$ Millions)$4,777
Inventory Turnover2.33